Codes ATC:
N02BA01
EMLc
Indication
Juvenile idiopathic arthritis
Code ICD11:
FA24.Z
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Additional notes
Acute or chronic use for rheumatic fever, juvenile arthritis , Kawasaki disease
Formulations
Oral > Solid:
100 to 500 mg
Local > Rectal > Suppository: 50 to 150 mg
Local > Rectal > Suppository: 50 to 150 mg
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
A new section of the Model Lists for “Medicines for diseases of joints” was created to list the treatments for gout and the disease-modifying agents used in rheumatoid disorders and juvenile joint diseases that were previously included in Section 2.
Thus, acetylsalicylic acid for the treatment of juvenile arthritis in children was transferred to this new section.